Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 6.82% is 236% above its 5-year average of -5.02%, near the high end of its 5-year range (-35.21%–11.29%).
322.37% above its 12-month average of 1.61%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -8.99%.
EBITDA MARGIN
6.82%
EBITDA MARGIN AVG TTM
1.61%
EBITDA MARGIN AVG 3Y
3.69%
EBITDA MARGIN AVG 5Y
-5.02%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+322.37%
CURRENT VS 3Y AVG
+84.67%
CURRENT VS 5Y AVG
+235.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Hims & Hers Health, Inc.
Market Cap
$6.21B
EBITDA Margin
6.82%
TTM Avg
1.61%
3Y Avg
3.69%
5Y Avg
-5.02%
Market Cap
$5.99B
EBITDA Margin
-395.82%
TTM Avg
-536.17%
3Y Avg
-471.62%
5Y Avg
-471.62%
Market Cap
$6.62B
EBITDA Margin
15.93%
TTM Avg
16.80%
3Y Avg
17.55%
5Y Avg
18.41%
Market Cap
$5.15B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
Market Cap
$8.41B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$3.04B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.21B | 6.82% | 1.61% | 3.69% | -5.02% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.99B | -395.82% | -536.17% | -471.62% | -471.62% |
| Chemed Corporation (CHE)vs › | $6.62B | 15.93% | 16.80% | 17.55% | 18.41% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.15B | 21.06% | 20.50% | 18.63% | 16.67% |
| Doximity, Inc. (DOCS)vs › | $4.83B | 35.56% | 38.69% | 36.58% | 34.55% |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | -3.14% | -1.08% | -5.02% | -19.32% |
| TransMedics Group, Inc. (TMDX)vs › | $3.04B | 22.42% | 17.70% | -0.76% | -37.34% |
| Insulet Corp. (PODD)vs › | $9.64B | 21.67% | 20.24% | 16.36% | 15.66% |
| Henry Schein, Inc. (HSIC)vs › | $9.97B | 8.11% | 8.11% | 8.28% | 8.19% |
| The Ensign Group, Inc. (ENSG)vs › | $10.07B | 10.47% | 10.43% | 10.38% | 10.85% |
Gross Margin
73.8%
EBITDA Margin
6.8%
Operating Margin
4.5%
Net Margin
-5.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -8.99% |
| 2026-03-31 | 0.90% |
| 2025-12-31 | 4.42% |
| 2025-09-30 | 4.92% |
| 2025-06-30 | 6.83% |
| 2025-03-31 | 11.29% |
| 2024-12-31 | 5.12% |
| 2024-09-30 | 6.66% |
| 2024-06-30 | 4.65% |
| 2024-03-31 | 4.64% |
| 2023-12-31 | 0.92% |
| 2023-09-30 | -2.73% |
| 2023-06-30 | -3.30% |
| 2023-03-31 | -4.79% |
| 2022-12-31 | -5.74% |
| 2022-09-30 | -12.48% |
| 2022-06-30 | -16.18% |
| 2022-03-31 | -14.98% |
| 2021-12-31 | -23.54% |
| 2021-09-30 | -35.21% |
| 2021-06-30 | -27.85% |
| 2021-03-31 | -91.78% |
| 2020-12-31 | -10.28% |
| 2020-09-30 | -7.31% |
| 2020-06-30 | -2.14% |
| 2020-03-31 | -20.08% |
| 2019-12-31 | -54.04% |
| 2019-09-30 | -89.60% |
| 2019-06-30 | -114.50% |
| 2019-03-31 | -114.50% |
